Abstracts of the Netherlands Ophthalmological Society (NOG) Annual Congress, 29-31 March 2017, Maastricht, Holland: CRISPR/Cas9, a powerful tool to target human herpesviruses

S. Imhof; J. de Boer; R. Wisse; E. J. H. J. Wiertz; F. F. van Diemen; R. J. Lebbink

doi:10.1111/aos.13419

Abstracts of the Netherlands Ophthalmological Society (NOG) Annual Congress, 29-31 March 2017, Maastricht, Holland: CRISPR/Cas9, a powerful tool to target human herpesviruses

S. Imhof
, J. de Boer
, R. Wisse
, E. J. H. J. Wiertz
, F. F. van Diemen
, R. J. Lebbink

Research output: Contribution to journal › Meeting Abstract › Other research output

Original language	English
Pages (from-to)	3-3
Journal	Acta Ophthalmologica
Volume	95
Issue number	S258
DOIs	https://doi.org/10.1111/aos.13419
Publication status	Published - Apr 2017

Access to Document

10.1111/aos.13419

Cite this

@article{76ef925503ce476d8b6c6b5b8e327573,

title = "Abstracts of the Netherlands Ophthalmological Society (NOG) Annual Congress, 29-31 March 2017, Maastricht, Holland: CRISPR/Cas9, a powerful tool to target human herpesviruses",

author = "S. Imhof and \{de Boer\}, J. and R. Wisse and Wiertz, \{E. J. H. J.\} and \{van Diemen\}, \{F. F.\} and Lebbink, \{R. J.\}",

year = "2017",

month = apr,

doi = "10.1111/aos.13419",

language = "English",

volume = "95",

pages = "3--3",

journal = "Acta Ophthalmologica",

issn = "1755-375X",

publisher = "John Wiley \& Sons Inc.",

number = "S258",

}

TY - JOUR

T1 - Abstracts of the Netherlands Ophthalmological Society (NOG) Annual Congress, 29-31 March 2017, Maastricht, Holland

T2 - CRISPR/Cas9, a powerful tool to target human herpesviruses

AU - Imhof, S.

AU - de Boer, J.

AU - Wisse, R.

AU - Wiertz, E. J. H. J.

AU - van Diemen, F. F.

AU - Lebbink, R. J.

PY - 2017/4

Y1 - 2017/4

UR - https://www.scopus.com/pages/publications/85057376851

U2 - 10.1111/aos.13419

DO - 10.1111/aos.13419

M3 - Meeting Abstract

SN - 1755-375X

VL - 95

SP - 3

EP - 3

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

IS - S258

ER -

Abstracts of the Netherlands Ophthalmological Society (NOG) Annual Congress, 29-31 March 2017, Maastricht, Holland: CRISPR/Cas9, a powerful tool to target human herpesviruses

Access to Document

Other files and links

Cite this